Quantbot Technologies LP Lowered Bristol (BMY) Stake By $2.05 Million; Capricor Therapeutics (CAPR) Has 4.33 Sentiment

March 20, 2018 - By Marie Mckinney

Quantbot Technologies Lp decreased Bristol (BMY) stake by 93.19% reported in 2017Q3 SEC filing. Quantbot Technologies Lp sold 32,510 shares as Bristol (BMY)’s stock declined 1.04%. The Quantbot Technologies Lp holds 2,377 shares with $151,000 value, down from 34,887 last quarter. Bristol now has $108.26B valuation. The stock increased 0.36% or $0.24 during the last trading session, reaching $66.31. About 1.73 million shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since March 20, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

Capricor Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company has market cap of $44.92 million. The companyÂ’s development stage drug candidates for cardiovascular diseases include CAP-1002 that is in Phase II clinical trials; and CAP-2003, which is in pre-clinical development for the treatment of certain cardiac and inflammatory conditions. It has a 19 P/E ratio.

Investors sentiment decreased to 0.94 in Q3 2017. Its down 0.09, from 1.03 in 2017Q2. It worsened, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares or 0.68% more from 1.10 billion shares in 2017Q2 were reported. Carderock Mngmt reported 8,675 shares. Sva Plumb Wealth Lc invested in 0.48% or 61,213 shares. The California-based Aimz Inv Advisors Limited Company has invested 0.24% in Bristol-Myers Squibb Company (NYSE:BMY). Salem Counselors holds 102,510 shares. Clearbridge Limited Com reported 2.67 million shares stake. Manning & Napier Advsr Ltd Company invested in 1.88M shares or 1.03% of the stock. Old Point Tru Svcs N A has invested 0.16% in Bristol-Myers Squibb Company (NYSE:BMY). 2.86 million were accumulated by Alliancebernstein Lp. Hutchinson Mgmt Ca owns 3,780 shares. Virginia-based Kanawha Cap Mngmt Ltd Liability Company has invested 0.68% in Bristol-Myers Squibb Company (NYSE:BMY). 102,400 are held by Louisiana State Employees Retirement System. 30.91 million are owned by Fmr Lc. Arete Wealth Advisors Ltd holds 10,379 shares or 0.26% of its portfolio. Strategic Wealth Group Llc holds 39,163 shares. Signaturefd Limited Co reported 0.13% in Bristol-Myers Squibb Company (NYSE:BMY).

Among 21 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 3 Sell and 11 Hold. Therefore 33% are positive. Bristol-Myers Squibb Company had 76 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, August 16 by Credit Suisse. The rating was upgraded by Piper Jaffray on Monday, August 24 to “Underweight”. The stock has “Hold” rating by Jefferies on Thursday, August 27. The company was initiated on Wednesday, April 6 by Societe Generale. Leerink Swann maintained the shares of BMY in report on Monday, October 23 with “Outperform” rating. BMO Capital Markets maintained the stock with “Sell” rating in Monday, June 5 report. The company was maintained on Tuesday, December 1 by Barclays Capital. The firm has “Hold” rating given on Friday, September 22 by Piper Jaffray. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Neutral” rating given on Friday, October 27 by Credit Suisse. The stock has “Market Perform” rating by BMO Capital Markets on Wednesday, April 5.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on April, 26. They expect $0.86 earnings per share, up 2.38% or $0.02 from last year’s $0.84 per share. BMY’s profit will be $1.40B for 19.28 P/E if the $0.86 EPS becomes a reality. After $0.68 actual earnings per share reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts 26.47% EPS growth.

Since December 12, 2017, it had 1 insider buy, and 1 sale for $85,985 activity. Lynch Thomas J. Jr. sold $335,172 worth of Bristol-Myers Squibb Company (NYSE:BMY) on Tuesday, December 12. Samuels Theodore R. II bought 4,000 shares worth $249,187.

Quantbot Technologies Lp increased Express Scripts Holding Co (NASDAQ:ESRX) stake by 6,663 shares to 19,130 valued at $1.21M in 2017Q3. It also upped Adr stake by 34,431 shares and now owns 40,004 shares. Nordstrom Inc (NYSE:JWN) was raised too.

The stock decreased 3.93% or $0.07 during the last trading session, reaching $1.71. About 67,053 shares traded. Capricor Therapeutics, Inc. (CAPR) has declined 72.31% since March 20, 2017 and is downtrending. It has underperformed by 89.01% the S&P500.

Apriem Advisors holds 0.04% of its portfolio in Capricor Therapeutics, Inc. for 50,000 shares. Granite Point Capital Management L.P. owns 33,750 shares or 0.02% of their US portfolio. Moreover, Cordasco Financial Network has 0.01% invested in the company for 3,100 shares. The New York-based Two Sigma Securities Llc has invested 0.01% in the stock. Bank Of America Corp De, a North Carolina-based fund reported 4,000 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: